Skip to content
The Colorado Natural Medicine Health Act Tracker and Bulletin are now live.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Colorado Natural Medicine Advisory Bulletin

      Everything you need to know about implementing the NMHA in Colorado.

      Read the Latest

      News & Press Releases

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Ibogaine Patents
      Ibogaine Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Law Trackers

      Mapping psychedelic drug policy reform across the United States and worldwide.

      Worldwide Tracker
      U.S. Tracker
      Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving Way for New Drug Application

Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving Way for New Drug Application

  • Post published:September 14, 2023
  • Post category:News
Read more about the article Psychedelic Research Bulletin: July and August 2023

Psychedelic Research Bulletin: July and August 2023

  • Post published:September 9, 2023
  • Post category:News/Psychedelics Research Review
Read more about the article California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments

California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments

  • Post published:September 1, 2023
  • Post category:News
Read more about the article BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m

BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m

  • Post published:August 31, 2023
  • Post category:News
Read more about the article Cybin Set to Acquire British DMT Drug Developer Small Pharma

Cybin Set to Acquire British DMT Drug Developer Small Pharma

  • Post published:August 28, 2023
  • Post category:News
Read more about the article Psychedelic Research Bulletin: June 2023

Psychedelic Research Bulletin: June 2023

  • Post published:July 10, 2023
  • Post category:News/Psychedelics Research Review
Read more about the article Psychedelic Research Bulletin: May 2023

Psychedelic Research Bulletin: May 2023

  • Post published:June 29, 2023
  • Post category:News/Psychedelics Research Review
Read more about the article State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine

State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine

  • Post published:May 31, 2023
  • Post category:News
Read more about the article MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

  • Post published:November 17, 2022
  • Post category:News/Press Release
Read more about the article BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

  • Post published:August 1, 2022
  • Post category:News

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.